Oneness Biotech Co., Ltd. (TPEX:4743)
Taiwan · Delayed Price · Currency is TWD 47.80
+0.85 (1.81%)
Aug 26, 2026, 1:30 PM CST
Oneness Biotech Market Cap
Oneness Biotech has a market cap or net worth of 22.51 billion as of August 25, 2026. Its market cap has decreased by -36.41% in one year.
Market Cap
22.51B
Enterprise Value
17.57B
Revenue
153.78M
Ranking
n/a
PE Ratio
370.08
Stock Price
47.80
ChartMarket Cap Chart
Since June 22, 2009, Oneness Biotech's market cap has increased from 1.24B to 22.51B, an increase of 1,715.42%. That is a compound annual growth rate of 18.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 22.51B | -15.39% |
| Dec 31, 2025 | 26.60B | -36.18% |
| Dec 31, 2024 | 41.68B | -52.65% |
| Dec 29, 2023 | 88.03B | -7.55% |
| Dec 30, 2022 | 95.22B | -13.04% |
| Dec 30, 2021 | 109.49B | 21.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CHO Pharma | 23.86B |
| Sunmax Biotechnology | 21.54B |
| Medigen Vaccine Biologics | 18.31B |
| TaiMed Biologics | 17.24B |
| EirGenix | 15.51B |
| Ever Supreme Bio Technology | 15.42B |
| Lumosa Therapeutics | 13.55B |
| Gongwin Biopharm Holdings | 13.03B |